Daily non-political popular news in brief.

Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss

A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.

Read more »

Keywords: promising, antiobesity, drug, fails, produce, clinically, meaningful, weight, loss, fail

« Previous | Next »

Similar news on "Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss":

1. Experimental weight-loss drug cuts appetite, burns more energy
   01-08-2008 · EurekAlert!
   The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose weight, even at very low doses. Short-term studies also suggest that the drug, called taranabant -- the second drug designed to fight obesity by blocking cannabinoid receptors in the brain -- causes people to consume fewer calories and burn more energy.
   Similar news · Read more »
   
2. How to lose weight and not go hungry: HU researcher develops drug that mimics feeling of 'fullness'
   06-06-2007 · EurekAlert!
   Millions of people the world over suffer today from obesity, yet there is no "magic bullet" that has yet provided a universally accepted solution. However, a young researcher at the Hebrew University of Jerusalem feels he has come up with a practical weight loss solution for the obese person without his having to feel hungry.
   Similar news · Read more »
   
3. Weight loss through calorie restriction, but not exercise, may lead to bone loss
   12-11-2006 · EurekAlert!
   Men and women who lose weight by cutting calories also may be losing bone density, but weight loss through exercise does not seem to produce the same effect, according to a report in the December 11/25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
   Similar news · Read more »
   
4. Promising drug fails to improve COPD symptoms
   05-01-2007 · EurekAlert!
   A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multicenter trial.
   Similar news · Read more »
   
5. Popular ADHD drug safe and effective for pre-schoolers
   10-23-2006 · EurekAlert!
   A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers. Investigators warn, however, that three to five-year-olds appear more sensitive to the drug's side effects, which include irritability, insomnia and weight loss, than are older children with ADHD and require closer monitoring.
   Similar news · Read more »
   
6. New drug makes weight loss safer
   09-26-2007 · EurekAlert!
   Dr. Nir Barak of TAU has adapted a well-known drug used to treat vertigo for a new purpose: to treat obesity without dangerous side effects.
   Similar news · Read more »
   
7. Annals of Internal Medicine tip sheet for July 3, 2007, issue
   07-02-2007 · EurekAlert!
   In this issue: Dietary counseling results in weight loss of approximately six percent of body weight after one year; Annals of Internal Medicine is 80! -- Still young and still reaching out; High dose of cholesterol-lowering drug reduces risk for major cardiovascular events in older as well as younger patients; Beta-blockers reduce plaque in artery walls; and Cystatin C level predicts death risk from three causes as well as usual tests.
   Similar news · Read more »
   
8. Does OTC diet pill Alli live up to its name?
   06-13-2007 · EurekAlert!
   Alli is the first and only FDA-approved OTC product for weight loss. It is available in stores June 15. Dr. James Anderson, UK HealthCare weight loss researcher, studied the effects of the drug on mildly to moderately overweight individuals and found it does aid weight loss.
   Similar news · Read more »
   
9. Sports cheats beware -- new test detects previously undetectable drug
   11-12-2006 · EurekAlert!
   Injecting performance enhancing corticosteroid hormones for other than medical treatment is banned, and tests exist that can detect injected hormones. Injecting synacthen, which stimulates the body to produce extra amounts of its own corticosteroid hormones is also banned. But until now there has been no test that could detect it in a blood sample.
   Similar news · Read more »
   
10. Leukemic cells find safe haven in bone marrow
    03-22-2007 · EurekAlert!
    The cancer drug asparaginase fails to help cure some children with acute lymphoblastic leukemia (ALL) because molecules released by certain cells in the bone marrow counteract the effect of that drug, according to investigators at St. Jude Children's Research Hospital.
    Similar news · Read more »